October 18, 2021
Why we like HeraMED:
· The HeraCARE platform is the only clinically validated, maternity care platform inexistence, with FDA clearance granted for its proprietary HeraBEAT device to be used in clinical or home settings with hospital grade accuracy of the device
· Multiple licensing agreement discussions underway globally and Paid Pilots in progress with:
─ Mednax Inc in the US, largest provider of Maternity services in the US supporting 1 in 4 babies delivered each year (1 million births per annum)
─ Joondalup Health Campus (Perth, WA – owned by Ramsay Health)
· Existing trials also current being undertaken by Mayo Clinic (US) on new HeraCARE platform AND Sheba Medical Group (Israel). Both ranked as Top 10 Healthcare groups globally
· Discussions currently underway with additional partners across leading obstetrics providers in the US, Europe and Australia
· Strong news-flow anticipated with:
─ Additional data being generated from past, current and future pilots and trials
─ Additional collaborations and partnerships
─ Commercial adoption from key partners
